Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telavancin PK in CKD5 Hemodialysis Patients
NCT02392208Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Jul 2015
- Primary completion
- Mar 2016
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of telavancin in bloodstream infection (BSI), sponsored by University of Michigan. Started Jul 2015; status: completed.
02
Drugs
telavancin
03
Conditions
bloodstream infection (BSI)
Beyond the preview
Go deeper on NCT02392208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02392208.